-
Half of Patients on PPIs for GERD Still Have Persistent Symptoms
drugs
December 25, 2019
Gastroesophageal reflux disorder (GERD) symptoms are common, and more than half of patients taking daily proton pump inhibitor (PPI) therapy continue to experience persistent symptoms, according to a study published online in Gastroenterology.
-
New Data from SPRAVATO™ Studies Showed Rapid Reduction of Depressive Symptoms
americanpharmaceuticalreview
September 10, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced positive results from two pivotal Phase 3 clinical studies (ASPIRE I & II) to evaluate the efficacy...
-
High-Sensitivity Troponin Levels Can Predict MI Risk
drugs
July 02, 2019
High-Sensitivity Troponin Levels Can Predict MI Risk.
-
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents
drugs
June 12, 2019
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents.
-
Irritable Bowel Symptoms Tied to Intestinal, Brain Abnormalities
drugs
June 10, 2019
Irritable Bowel Symptoms Tied to Intestinal, Brain Abnormalities.
-
FDA Approves Xofluza, a First-In-Class Flu Drug to Treat Symptoms
drugs
November 01, 2018
FDA Approves Xofluza, a First-In-Class Flu Drug to Treat Symptoms
-
Sanofi's Dupixent improves symptoms for adolescent atopic dermatitis patients
pharmafile
September 20, 2018
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic dermatitis in patients...
-
Novartis' Cosentyx Shows Improvements In Signs And Symptoms For Both AS And PsA
newsnow
June 15, 2017
Novartis' Cosentyx Shows Improvements In Signs And Symptoms For Both AS And PsA